AJP - Renal Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 296: F284-F290, 2009. First published December 17, 2008; doi:10.1152/ajprenal.90647.2008
0363-6127/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/2/F284    most recent
90647.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, J.
Right arrow Articles by Ma, H.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, J.
Right arrow Articles by Ma, H.-P.

Cyclosporine stimulates the renal epithelial sodium channel by elevating cholesterol

Jing Wang,1,* Zhi-Ren Zhang,2,* Chu-Fang Chou,1,* You-You Liang,1 Yuchun Gu,3 and He-Ping Ma1

1Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; 2Departments of Pharmacy and Cardiology, the 2nd Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China; and 3Department of Physiology, University of Birmingham, The Medical School, Edgbaston, United Kingdom

Submitted 29 October 2008 ; accepted in final form 11 December 2008

Cyclosporine A (CsA) is an efficient immunosuppressant used for reducing allograft rejection but with a severe side effect of causing hypertension. We hypothesize that the renal epithelial sodium channel (ENaC) may participate in CsA-induced hypertension. In the present study, we used the patch-clamp cell-attached configuration to examine whether and how CsA stimulates ENaC in A6 distal nephron cells. The data showed that CsA significantly increased ENaC open probability. Since CsA is an inhibitor of the ATP-binding cassette A1 (ABCA1) transporter, we employed 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS), another ABCA1 inhibitor, and found that DIDS mimicked the effects of CsA on ENaC basal and cholesterol-induced activity but without any additive effect if combined with CsA. CsA and DIDS also had an identical effect on reduced ENaC activity caused by cholesterol extraction. ABCA1 protein was detected in A6 cells by Western blot analysis. Confocal microscopy data showed that both CsA and DIDS facilitated A6 cells to uptake cholesterol. Since enhanced ENaC activity is known to cause hypertension, these data together suggest that CsA may cause hypertension by stimulating ENaC through a pathway associated with inhibition of ABCA1 and consequent elevation of cholesterol in the cells.

patch-clamp technique; confocal microscopy; cyclosporine A; ATP-binding cassette transporter A1; hypertension



Address for reprint requests and other correspondence: H.-P. Ma, Dept. of Medicine, Division of Nephrology, Univ. of Alabama at Birmingham, 1530 Third Ave. South, Zeigler Research Bldg. 510, Birmingham, AL 35294 (e-mail: hepingma{at}uab.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.